Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis

door Debled, M, Houédé, N, Madranges, N, Donamaria, C, Floquet, A, Durand, M, Mauriac, Louis
Gepubliceerd in 2007

Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

door Houédé, N., Locker, G., Lucas, C., Parra, H. Soto, Basso, U., Spaeth, D., Tambaro, R., Basterretxea, L., Morelli, F., Theodore, C., Lusuardi, L., Lainez, N., Guillot, A., Tonini, G., Bielle, J., Del Muro, X. Garcia
Gepubliceerd in BMC Cancer (2016)

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

door Pouessel, D., Neuzillet, Y., Mertens, L. S., van der Heijden, M. S., de Jong, J., Sanders, J., Peters, D., Leroy, K., Manceau, A., Maille, P., Soyeux, P., Moktefi, A., Semprez, F., Vordos, D., de la Taille, A., Hurst, C. D., Tomlinson, D. C., Harnden, P., Bostrom, P. J., Mirtti, T., Horenblas, S., Loriot, Y., Houédé, N., Chevreau, C., Beuzeboc, P., Shariat, S. F., Sagalowsky, A. I., Ashfaq, R., Burger, M., Jewett, M. A. S., Zlotta, A. R., Broeks, A., Bapat, B., Knowles, M. A., Lotan, Y., van der Kwast, T. H., Culine, S., Allory, Y., van Rhijn, B. W. G.
Gepubliceerd in Ann Oncol (2016)